GF Fund Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8K Buy
415
+48
+13% +$1.18K ﹤0.01% 537
2025
Q4
$7.66K Sell
367
-36
-9% -$669 ﹤0.01% 601
2025
Q3
$6.32K Buy
403
+26
+7% +$537 ﹤0.01% 593
2025
Q2
$7.49K Hold
377
﹤0.01% 597
2025
Q1
$6.68K Buy
377
+67
+22% +$2.18K ﹤0.01% 605
2024
Q4
$14.3K Buy
+310
New +$13.1K ﹤0.01% 503

Other funds holding TECX

GF Fund Management's TECX Position: Q1 2026 in Review

GF Fund Management increased its Tectonic Therapeutic (TECX) stake by 13% in Q1 2026, buying an estimated $1.18K and bringing the position to 415 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

GF Fund Management first reported a position in TECX in Q4 2024 and has held it in 6 quarters since. The position peaked at $14.3K in Q4 2024. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • GF Fund Management held 415 shares of Tectonic Therapeutic worth $12.8K as of Q1 2026.
  • GF Fund Management bought 48 Tectonic Therapeutic shares in Q1 2026, an estimated $1.18K.
  • Tectonic Therapeutic made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #537 holding.
  • GF Fund Management first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 6 quarters since.
  • GF Fund Management's Tectonic Therapeutic position peaked at $14.3K in Q4 2024.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.